Emollient creams and ointments, colloidal oatmeal-containing
Brand names: Aveeno cream, Aveeno lotion
These are leave-on emollient creams and ointments containing colloidal oatmeal, used to moisturise and soothe dry, itchy skin conditions such as eczema and other pruritic dermatoses.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
The emollient base reduces transepidermal water loss to restore the skin barrier, while colloidal oatmeal provides additional hydrating, anti-irritant and antipruritic soothing effects.
Prescribing in practice
- As with other paraffin-containing emollients, residue absorbed into clothing, bedding and dressings is flammable and patients must be advised to avoid naked flames and smoking.
- Colloidal oatmeal can rarely provoke contact sensitisation, so review if irritation or worsening rash develops.
- Use generously and frequently as a leave-on treatment rather than only at flares.
Monitoring
No blood monitoring is required; review skin hydration, itch control and any local reaction at follow-up.
Counselling the patient
- Smooth on liberally and often, especially after washing, in the direction of hair growth.
- Keep away from naked flames and avoid smoking; the product on skin and fabrics is flammable.
- Stop and seek advice if the skin becomes more irritated.
Evidence & guidelines
Emollients are central to dry-skin and eczema care in NICE guidance, with colloidal oatmeal valued for its soothing, antipruritic properties.
Reference: NICE CKS Eczema; BAD; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD